Show an ad over header. AMP

Axios-Ipsos poll: Trump's sickness makes him harder to trust

Data: Axios/Ipsos poll; Note: ±3.3% margin of error; Chart: Axios Visuals

Large shares of women, seniors and independents now say they're less likely to trust President Trump for accurate information about COVID-19 since he caught it himself, according to the latest installment of the Axios/Ipsos Coronavirus Index.

The big picture: Week 28 of our national survey has most Americans rejecting ideas that Trump has floated around hydroxychloriquine as a virus treatment, how herd immunity works or any imminent availability of a vaccine.


  • Eight in 10 fear local cases will rise and force new lockdowns and business closures.
  • Three-fourths of respondents say attending campaign rallies is risky.
  • That's true for majorities of Republicans (54%) as well as independents (79%) and especially Democrats (93%) — and it suggests that Joe Biden's decision to scrap large events to protect the public and himself doesn't carry much political risk.

Why it matters: Trump can ill afford to lose more women, seniors or independents with two weeks until the end of the election, according to national and battleground state polls.

  • The new findings reflect how the science around coronavirus is unifying Democrats but a wedge for Republicans — and how Trump's own messaging has painted him into a corner where he must rely more and more on his base to pick up the slack for others he's alienated.

What they're saying: “It makes it very hard for Donald Trump to steer public opinion about the pandemic," said pollster Chris Jackson, senior vice president for Ipsos Public Affairs.

  • "It’s very hard for him to control the debate about COVID in any way because people have such little trust in what he says.”

By the numbers: Over the past two weeks, public opinion has turned more sharply against Trump's trustworthiness on information about the virus, from a 6 percentage point gap to 21.

  • 37% of overall respondents in the most recent survey say his diagnosis makes them less likely to trust him, while 16% say they're more likely to trust him and the rest are unchanged.
  • In the Oct. 1-5 survey, only 23% said they trusted him less and 17% said they were more likely to trust him.
  • 62% of Democrats, 44% of seniors 65 and over, 41% of women and 40% of independents — but only 11% of Republicans — said they're less likely to trust Trump's guidance now when it comes to the virus.

Between the lines: Republicans are far more likely than Democrats or independents to incorrectly believe that hydroxychloroquine was proven an effective treatment; that a vaccine would be available by election day; or that the U.S. could reach herd immunity with only a few additional deaths.

  • Republicans also are less likely to say it is true there was a pause in some trials due to safety concerns; that the virus can be spread without symptoms; or that wearing a mask limits person-to-person spread.
  • 71% of Democrats, 58% of independents and 27% of Republicans answered all six questions correctly.
  • More than one in five Republicans got half or more of the questions wrong, compared with around 7% of Democrats.
  • People with no major source of news or who primarily watch Fox News had the highest correlations to incorrect answers.

Methodology: This Axios/Ipsos Poll was conducted Oct.16–19 by Ipsos’ KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,001 general population adults age 18 or older.

  • The margin of sampling error for the full sample is +/- 3.3 percentage points.

"Relaxing too fast": Europeans extend COVID lockdowns to reduce risk of Christmas third wave

Recent spikes in COVID-19 infections across Europe have led authorities to extend restrictions ahead of the holiday season.

Why it matters: "Relaxing too fast and too much is a risk for a third wave after Christmas," said European Commission President Ursula von der Leyen.

Keep reading... Show less

Expert says COVID vaccine likely won't be available in Africa until Q2 of 2021

Africa may have to wait until the second quarter of 2021 to roll out vaccines, Africa CDC director John Nkengasong said Thursday, according to the Associated Press.

Why it matters: “I have seen how Africa is neglected when drugs are available,” Nkengasong said.

Keep reading... Show less

The winners and losers of the COVID holiday season

The pandemic has upended Thanksgiving and the shopping season that the holiday kicks off, creating a new crop of economic winners and losers.

The big picture: Just as it has exacerbated inequality in every other facet of American life, the coronavirus pandemic is deepening inequities in the business world, with the biggest and most powerful companies rapidly outpacing the smaller players.

Keep reading... Show less

Coronavirus cases rose 10% in the week before Thanksgiving

Data: The COVID Tracking Project, state health departments; Map: Andrew Witherspoon, Sara Wise/Axios

The daily rate of new coronavirus infections rose by about 10 percent in the final week before Thanksgiving, continuing a dismal trend that may get even worse in the weeks to come.

Why it matters: Travel and large holiday celebrations are most dangerous in places where the virus is spreading widely — and right now, that includes the entire U.S.

Keep reading... Show less

Supreme Court backs religious groups on New York coronavirus restrictions

The U.S. Supreme Court ruled late Wednesday that restrictions imposed on New York places of worship by Gov. Andrew Cuomo (D) during the coronavirus pandemic violated the First Amendment, per Bloomberg.

Why it matters: The decision in a 5-4 vote heralds one of the first significant actions by the new President Trump-appointed conservative Justice Amy Coney Barrett, who cast the deciding vote in favor of the Catholic Church and Orthodox Jewish synagogues.

Editor's note: This a breaking news story. Please check back for updates.

Trump agency head who often skips mask tests positive for coronavirus

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of top administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Keep reading... Show less

COVID-19 shows a bright future for vaccines

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.

Keep reading... Show less

Beware a Thanksgiving mirage

Don't be surprised if COVID metrics plunge over the next few days, only to spike next week.

Why it matters: The COVID Tracking Project warns of a "double-weekend pattern" on Thanksgiving — where the usual weekend backlog of data is tacked on to a holiday.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories